Corvus Pharmaceuticals CRVS Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's change in AP?
- Corvus Pharmaceuticals (CRVS) reported change in AP of $2.21M in Q1 2026.
- How has Corvus Pharmaceuticals's change in AP changed year-over-year?
- Corvus Pharmaceuticals's change in AP increased by 273.2% year-over-year, from -$1.27M to $2.21M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.